News
UK Election analysis and Brexit – Part 3
Last week’s UK general election gamble paid off for Boris Johnson. For the Conservatives it was the largest majority achieved in parliament since 1987 and for Labour, the worst performance since 1935. The Conservative party have redrawn the political map in England, erasing Labours traditional dominance in the Midlands and North of England. As in 2017 the UK polling company Survation proved to be the most accurate again, projecting an 11% lead for the Conservatives against an actual result of 11.5%.
Australia’s high-grade iron ore marks as a key player as the world transitions towards reduced carbon emissions
High Grade Iron Ore Report Part 1. A huge part of the global climate debate is spoken in absolutes. Debate rages over authenticity of scientific reports and clear, broad definitions. Politicians, key business sectors and various business parties have all seen fit to bend narratives in their favour, with defined two sided questions dividing the public for decades.
Reach Markets Holiday Opening Hours
The Christmas break is nearly here. We’ll continue to provide our support and services over the holiday period but there will some adjustments between December 24 to January 2.
UK Election analysis and Brexit – Part 2
Wednesday is the final day of campaigning in a UK election dominated by Brexit and the NHS. Both Boris Johnson and Jeremy Corbyn have had a bruising final week. Johnson was ambushed by a reporter with a picture of a young boy with pneumonia sleeping on a hospital floor
Tapping into an explosive modular data centre growth market – interview with Matthew Madden, CEO of DXN Limited
One-on-one with Matthew Madden, CEO of DXN Solutions. One thing better than having access to a valuable colocation data centre business – is having access to a prefabricated modular data centre market growing at a compound annual growth rate of 20%. DXN wants to grow their modular data centre service to a vicinity of $60 million plus per annum, in addition to annuity income from maintenance services and expanding on their colocation services.
How to benefit from market uncertainty
Starting on March 9, 2009 and still going strong, we’re in the middle of the longest bull run ever. Almost 11 years later, the S&P 500 has seen a 468% gain. It’s now the best performing bull market since WWII. But can it continue?
UK Election analysis and Brexit – Part 1
With just over a week to go and the polls narrowing there is still little certainty over how and when Brexit will happen. At the start of the campaigning period Brexit was at the heart of discussion but has somewhat taken a back seat with accusations of Anti-Semitism in the Labour party and questions over the Conservative parties plans for the National Health Service taking centre stage.
Disruption Risk – Everywhere! Ignore at your peril
Understanding disruption risk is one of the key drivers of avoiding underperforming businesses. This is critical in a world where most businesses are experiencing significant turbulence because of the disruptive effects of the most significant demographic shifts with 4.4bn millennials and centennials driving new consumption patterns.
What is going to happen in the market? The experts disagree but you can use that to your advantage
Diversification is the key to building a robust portfolio. Gold and stocks are not closely correlated investments, so a healthy portfolio could have a mix of both.
Technical Analysis – Identifying a Breakout
Traders like to use price action to predict what may happen in the short term. With hundreds of different indicators to choose from, and many different approaches to trading, how do you get an edge?
How targeted cancer therapies could change the healthcare industry
This week we were joined in office by Prescient Therapeutics (ASX: PTX) CEO and Managing Director Steven Yatomi-Clarke for an investor and industry update in the personalised medicine and cancer therapy space.
From untreatable to curable? The evolution of cancer treatment
Humankind has been trying to find a cure for cancer for thousands of years. Today, we may have reached a point where we know enough to develop an effective cancer cure and the question remains, where will science take us next?
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.